# Trade Mark Journal No.2026/009 27 February 2026

## WO0000001898532 (9,35,41,44)

Office of origin: United States of America

Date of International Registration:4 November 2024
Date of designation in the UK: 4 November 2024

International priority date claimed: 3 May 2024 (United States of America) (98533430)
International priority date claimed: 3 May 2024 (United States of America) (98533442)

Class 9
  Instructional and educational materials in the nature of electronic publications, namely, downloadable brochures concerning healthcare and medicine.
Class 35
  Promoting public awareness of medical conditions, medical research, and options for diagnosis, treatment, and management; promoting public awareness by means of public advocacy of medical conditions, medical research, and options for diagnosis, treatment, and management.
Class 41
  Educational services, namely, providing educational speakers, classes, workshops, conferences, and seminars in the fields of healthcare and medicine, and distribution of training materials in connection therewith; organisation of educational webinars in the fields of healthcare and medicine; production of instructional and educational materials, including newsletters and brochures concerning healthcare and medicine; providing non-downloadable electronic publications in the nature of non-downloadable electronic brochures concerning healthcare and medicine.
Class 44
  Providing medical information; providing online information about medical services; providing information in the fields of healthcare, medicine, and cancer and oncological disorders via a website.

Jazz Pharmaceuticals Ireland Limited

Representative: Michael T. Olsen Winthrop & Weinstine, P.A., 225 South 6th Street, Suite 3500, Minneapolis MN 55402, UNITED STATES OF AMERICA